Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Milano

Showing results (1-10 of 347) with videos related to

Pageof 35
Sort By:
Rivista Dell'Infermiere|August 14, 1999
[Comparisons: expectations and demands of society. Reflections on patients' rights]G Milano
Bulletin Du Cancer|January 1, 1995
[Increase of dose intensity by pharmacomodulation. General concepts and therapeutic applications]G Milano
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 2, 2017
Is the pursuit of a higher impact factor fully justified?G Milano
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 23, 2017
DPD testing must remain a recommended option, but not a recommended routine testG Milano
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 21, 2017
Don't forget the host: a potential role for germinal polymorphisms as markers for checkpoint inhibitorsG Milano
Epidemiologia E Prevenzione|October 28, 1998
[Di Bella case: apropos of ethics of information]G Milano
Bulletin Du Cancer|May 1, 1993
[Dosage adjustment of antineoplastic agents in clinical practice]G Milano
Cancer Chemotherapy and Pharmacology|April 14, 2019
Efficacy of immunotherapy, gut microbiota and impact of antibiotic use: are there confounding factors?G Milano
Bulletin Du Cancer|December 1, 1994
[Drug resistance: from the laboratory to the clinic. Variations in drug resistance with time]G Milano
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 19, 2022
Fewer cetuximab-related skin-toxicities in colorectal cancer patients treated with encorafenib: a Yin and Yang effect of ERK paradoxical activationJ Ciccolini, G Milano
Pageof 35

Showing results (1-10 of 347) with videos related to

Sort By:
Pageof 35
Rivista Dell'Infermiere|August 14, 1999
[Comparisons: expectations and demands of society. Reflections on patients' rights]G Milano
Bulletin Du Cancer|January 1, 1995
[Increase of dose intensity by pharmacomodulation. General concepts and therapeutic applications]G Milano
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 2, 2017
Is the pursuit of a higher impact factor fully justified?G Milano
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 23, 2017
DPD testing must remain a recommended option, but not a recommended routine testG Milano
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 21, 2017
Don't forget the host: a potential role for germinal polymorphisms as markers for checkpoint inhibitorsG Milano
Epidemiologia E Prevenzione|October 28, 1998
[Di Bella case: apropos of ethics of information]G Milano
Bulletin Du Cancer|May 1, 1993
[Dosage adjustment of antineoplastic agents in clinical practice]G Milano
Cancer Chemotherapy and Pharmacology|April 14, 2019
Efficacy of immunotherapy, gut microbiota and impact of antibiotic use: are there confounding factors?G Milano
Bulletin Du Cancer|December 1, 1994
[Drug resistance: from the laboratory to the clinic. Variations in drug resistance with time]G Milano
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 19, 2022
Fewer cetuximab-related skin-toxicities in colorectal cancer patients treated with encorafenib: a Yin and Yang effect of ERK paradoxical activationJ Ciccolini, G Milano
Pageof 35